Cargando…

METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS

The present study aimed to explore the potential roles of the methyltransferase-like 3 (METTL3)-mediated methylation of RAS related (RRAS) mRNA in the tumorigenesis and development of bladder cancer (BCa). For this purpose, the relative expression levels of METTL3 in BCa specimens and cell lines wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jie-Xun, Chen, Dong-Ming, Wang, Dong, Xiao, Yi, Zhu, Shuai, Xu, Xian-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086563/ https://www.ncbi.nlm.nih.gov/pubmed/36960869 http://dx.doi.org/10.3892/or.2023.8531

Ejemplares similares

METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5
por: Zhou, Dan, et al.
Publicado: (2021)

YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR Axis
por: Zhu, Junlong, et al.
Publicado: (2023)

DDX5/METTL3-METTL14/YTHDF2 Axis Regulates Replication of Influenza A Virus
por: Zhao, Lingcai, et al.
Publicado: (2022)

METTL3/YTHDF2 m(6)A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer
por: Xie, Haiyun, et al.
Publicado: (2020)

METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner
por: Xu, Qiong-Cong, et al.
Publicado: (2022)

RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis
por: Li, Yi, et al.
Publicado: (2022)

RRas2, RhoG and T-cell phagocytosis
por: Alarcón, Balbino, et al.
Publicado: (2012)

MEF2C Expression Is Regulated by the Post-transcriptional Activation of the METTL3-m(6)A-YTHDF1 Axis in Myoblast Differentiation
por: Yang, Xinran, et al.
Publicado: (2022)

METTL3 promotes cell cycle progression via m(6)A/YTHDF1-dependent regulation of CDC25B translation
por: Li, Huifeng, et al.
Publicado: (2022)

Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing’s sarcoma
por: Jiang, Jie, et al.
Publicado: (2022)

YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m(6)A modification to activate NF-κB and promote the malignant progression of glioma
por: Chai, Rui-Chao, et al.
Publicado: (2021)

METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer
por: Zhan, Lei, et al.
Publicado: (2023)

METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism
por: Wang, Yongjie, et al.
Publicado: (2022)

The m(6)A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
por: Zhang, Lei, et al.
Publicado: (2023)

METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m(6)A-YTHDF2-dependent manner
por: Li, Jiaren, et al.
Publicado: (2022)

Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer
por: Wang, Fang, et al.
Publicado: (2023)

METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding
por: Wang, Wei, et al.
Publicado: (2021)

METTL1‐m(7)G‐EGFR/EFEMP1 axis promotes the bladder cancer development
por: Ying, Xiaoling, et al.
Publicado: (2021)

METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m(6)A-YTHDF2–dependent mechanism
por: Hou, Xiaoxue, et al.
Publicado: (2023)

RRAS2 shapes the TCR repertoire by setting the threshold for negative selection
por: Martínez-Riaño, Ana, et al.
Publicado: (2019)

METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion
por: Zhang, Zhe, et al.
Publicado: (2016)

YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation
por: Li, Jiong, et al.
Publicado: (2021)

METTL3 Regulated the Meat Quality of Rex Rabbits by Controlling PCK2 Expression via a YTHDF2–N6-Methyladenosine Axis
por: Luo, Gang, et al.
Publicado: (2022)

Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11
por: Fan, Zhuoyang, et al.
Publicado: (2021)

Author Correction: METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding
por: Wang, Wei, et al.
Publicado: (2021)

In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies
por: van Engelen, Nienke, et al.
Publicado: (2022)

Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)

Retraction Note: METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion
por: Zhang, Zhe, et al.
Publicado: (2023)

Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
por: Flex, Elisabetta, et al.
Publicado: (2014)

Identification of RRAS gene related to nasopharyngeal carcinoma based on pathway and network-based analyses
por: Xiao, Ruowen, et al.
Publicado: (2019)

The Hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?
por: Tan, Mark T. L., et al.
Publicado: (2019)

Epigenetic m6A RNA Modification Reader YTHDF1 in Merkel Cell Carcinoma
por: Jaguri, Aayami, et al.
Publicado: (2023)

METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B‐cell lymphoma cells
por: Feng, Lili, et al.
Publicado: (2023)

Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2022)

The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus
por: Luo, Qing, et al.
Publicado: (2020)

METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m(6)A Modification
por: Zhao, Wei, et al.
Publicado: (2020)

Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
por: Hortal, Alejandro M., et al.
Publicado: (2022)

Response to the hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-barr virus?
por: Xiao, Ruowen, et al.
Publicado: (2019)

Correction to: Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8gvacrb0lop3d864c8fqiadtgd